Article Versions Notes

Orel VE, Diedkov AG, Ostafiichuk VV, Lykhova OO, Kolesnyk DL, Orel VB, Dasyukevich OY, Rykhalskyi OY, Diedkov SA, Prosvietova AB. Combination Treatment with Liposomal Doxorubicin and Inductive Moderate Hyperthermia for Sarcoma Saos-2 Cells. Pharmaceuticals. 2024; 17(1):133. https://doi.org/10.3390/ph17010133

Orel, Valerii E., Anatoliy G. Diedkov, Vasyl V. Ostafiichuk, Oleksandra O. Lykhova, Denys L. Kolesnyk, Valerii B. Orel, Olga Yo. Dasyukevich, Oleksandr Yu. Rykhalskyi, Serhii A. Diedkov, and Anna B. Prosvietova. 2024. "Combination Treatment with Liposomal Doxorubicin and Inductive Moderate Hyperthermia for Sarcoma Saos-2 Cells" Pharmaceuticals 17, no. 1: 133. https://doi.org/10.3390/ph17010133

Orel, V. E., Diedkov, A. G., Ostafiichuk, V. V., Lykhova, O. O., Kolesnyk, D. L., Orel, V. B., Dasyukevich, O. Y., Rykhalskyi, O. Y., Diedkov, S. A., & Prosvietova, A. B. (2024). Combination Treatment with Liposomal Doxorubicin and Inductive Moderate Hyperthermia for Sarcoma Saos-2 Cells. Pharmaceuticals, 17(1), 133. https://doi.org/10.3390/ph17010133